Aprogen Medicines Inc. (KRX:007460)
South Korea flag South Korea · Delayed Price · Currency is KRW
751.00
-1.00 (-0.13%)
Last updated: Mar 27, 2025

Aprogen Medicines Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-58,079-55,619-98,657-93,920-46,490
Upgrade
Depreciation & Amortization
24,30529,07128,39225,2624,308
Upgrade
Loss (Gain) From Sale of Assets
201.14-30.3457.39-3.45
Upgrade
Asset Writedown & Restructuring Costs
801.872,2719,162223.61241.5
Upgrade
Loss (Gain) From Sale of Investments
-303-341.932,7441,2281,825
Upgrade
Loss (Gain) on Equity Investments
--1,4899,5439,780
Upgrade
Stock-Based Compensation
1,7181,613707.672,445-
Upgrade
Provision & Write-off of Bad Debts
1,573-8.5-5,001--74.85
Upgrade
Other Operating Activities
-18,663-19,249-35,587-17,92651,030
Upgrade
Change in Accounts Receivable
-207.691,7493,395778.844,177
Upgrade
Change in Inventory
1,270-5,024-17,526-8,36741.12
Upgrade
Change in Accounts Payable
-4,369-3,491-1,8523,378-28.79
Upgrade
Change in Unearned Revenue
-----166.97
Upgrade
Change in Income Taxes
-217.8935.78770.88378.18
Upgrade
Change in Other Net Operating Assets
6,761-9,315-2,151-8,155-2,491
Upgrade
Operating Cash Flow
-44,992-58,156-113,491-84,74022,534
Upgrade
Capital Expenditures
-12,671-25,514-19,610-34,392-2,576
Upgrade
Sale of Property, Plant & Equipment
83.042,273131.6540.0654.15
Upgrade
Cash Acquisitions
--39,940--
Upgrade
Divestitures
--29,285--
Upgrade
Sale (Purchase) of Intangibles
-10,473-29,371-5,209-474.06-391.26
Upgrade
Investment in Securities
-9,446965.6827,26818,390-19,407
Upgrade
Other Investing Activities
-7,9988,193-1,690-924.3-61,133
Upgrade
Investing Cash Flow
-40,504-43,45270,172-12,790-168,494
Upgrade
Short-Term Debt Issued
11,05014,61096,500134,190-
Upgrade
Long-Term Debt Issued
36,35096,546-30,84570,000
Upgrade
Total Debt Issued
47,400111,15696,500165,03570,000
Upgrade
Short-Term Debt Repaid
-11,350-40,110-7,500-27,000-
Upgrade
Long-Term Debt Repaid
-12,967-8,481-1,873-30,220-643.93
Upgrade
Total Debt Repaid
-24,317-48,591-9,373-57,220-643.93
Upgrade
Net Debt Issued (Repaid)
23,08362,56587,127107,81569,356
Upgrade
Issuance of Common Stock
0.765,51530.972,583132,876
Upgrade
Repurchase of Common Stock
-0.1--15,791--
Upgrade
Other Financing Activities
63,53726,216-561.9-0-31,222
Upgrade
Financing Cash Flow
86,62194,29670,804110,398171,010
Upgrade
Foreign Exchange Rate Adjustments
352.04-72.93-309.074.05-105.81
Upgrade
Net Cash Flow
1,477-7,38527,17612,87224,944
Upgrade
Free Cash Flow
-57,662-83,669-133,101-119,13219,957
Upgrade
Free Cash Flow Margin
-38.41%-55.57%-169.88%-453.05%15.70%
Upgrade
Free Cash Flow Per Share
-223.38-355.02-657.66-687.14352.97
Upgrade
Cash Interest Paid
630.7242.7610,99211,339875.83
Upgrade
Cash Income Tax Paid
220.01-2,1283,291398.92294.64
Upgrade
Levered Free Cash Flow
-43,846-21,656-145,21326,095-48,660
Upgrade
Unlevered Free Cash Flow
-43,216-21,261-139,02239,697-45,391
Upgrade
Change in Net Working Capital
-10,939-62,54869,884-108,26548,509
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.